A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma

Update Il y a 4 ans
Reference: NCT00762255

Woman and Man

Extract

The purpose of the this study is to see if an investigations cancer treatment called vorinostat can be combined with the irinotecan/bevacizumab regimen safely.


Inclusion criteria

  • Glioblastoma

Links